Who is sponsoring NCT02434471?

NCT02434471 is sponsored by Duke University.

What drugs are being tested in NCT02434471?

Interventions in NCT02434471: Respiratory-triggered T1w DISCO LAVA.

What condition does NCT02434471 study?

NCT02434471 studies Abdominal MRI.

Is NCT02434471 still recruiting?

NCT02434471 is currently completed. Last updated 2 July 2018.

Are results published for NCT02434471?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-07-02 · How we verify

NCT02434471

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single Breath Hold Abdominal MRI

Completed NA Results posted Last updated 2 July 2018

What this trial tests

NA trial testing Respiratory-triggered T1w DISCO LAVA in Abdominal MRI in 54 participants. Completed in 1 June 2017.

Timeline

12 January 2016

Primary endpoint
1 June 2017

1 June 2017

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	54
Start date	12 January 2016
Primary completion	1 June 2017
Estimated completion	1 June 2017
Sites	1 location across United States

Drugs / interventions tested

Respiratory-triggered T1w DISCO LAVA

Conditions studied

Abdominal MRI — all drugs for Abdominal MRI →

Sponsor

Duke University

Who can join

18 and older, any sex, with Abdominal MRI. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Motion Artifact Scores Primary · During MRI, up to 60 minutes

Three investigators will independently evaluate MRI examinations. They will assign motion scores between respiratory triggered and corresponding breath hold acquisitions. 1 = no motion artifact; 2 = minimal motion artifact, no effect on diagnostic quality; 3 = moderate motion artifact with some, but not severe, effect on diagnostic quality; 4 = severe motion artifact, images degraded but interpretable; and 5 = extensive motion artifact, images nondiagnostic.

Group	Value	95% CI
Breath Hold Liver Acquisition With Volume Acquisition (LAVA)	1.8	± 1.0
Respiratory-triggered T1w DISCO LAVA	2.4	± 0.9

Noise Scores Primary · During MRI, up to 60 minutes

Three investigators will independently evaluate MRI examinations. They will assign noise scores between respiratory triggered and corresponding breath hold acquisitions. 1 = no noise artifact; 2 = minimal noise artifact, no effect on diagnostic quality; 3 = moderate noise artifact with some, but not severe, effect on diagnostic quality; 4 = severe noise artifact, images degraded but interpretable; and 5 = severe noise artifact, images nondiagnostic.

Group	Value	95% CI
Breath Hold Liver Acquisition With Volume Acquisition (LAVA)	1.7	± 0.6
Respiratory-triggered T1w DISCO LAVA	1.8	± 0.7

Sponsor's own description

The purpose of this study is to evaluate a single breath hold abdominal MRI protocol and compare the image quality of respiratory triggered 3D T1-weighted images against conventional breath hold images.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02434471 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 2 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02434471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing